Sponsor Pipeline

Regend Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1
1
Early Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07275788 A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney… Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) Recruiting
Early Phase 1
NCT07239895 Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells Pediatric Bronchiolitis Obliterans Recruiting
NCT07355868 Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy Chronic Obstructive Pulmonary Disease (COPD) Recruiting
NCT07359963 Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy Idiopathic Pulmonary Fibrosis (IPF) Not Yet Recruiting
Disease Areas
Get alerts when Regend Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free